GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Official Journal of the Generics and Biosimilars Initiative
Volume 1 / Year 2012 / Issue 3-4
Letters to the Editor
A clinician’s view of the ethics of the use of biosimilars
Author(s): Dr Kalle Hoppu
Page: 112Abstract: Comment on the Letters to the Editor by Dr Carlo Petrini: A bioethicist’s view of the use of biosimilars Submitted: 8 October 2012; Revised: 9 October 2012; Accepted: 9 October 2012; Published online first: 11 October 2012 In the European Union the word ‘biosimilar’ denotes a copy version of an already authorized biological medicinal product with […]
A bioethicist’s view of the use of biosimilars
Author(s): Carlo Petrini, PhD
Page: 110-1Abstract: In recognition of the many ethically sensitive issues raised by the production and use of biosimilar medicinal products, the author imagines having to answer the non-multiple choice question ‘From the ethical point of view, what is the most important issue raised by biosimilars?’, and endeavours to explain why the proposed answer is ‘safety’. Submitted: […]
